Author Bandelow, Borwin

1 to 50 of 153 Items

2000 | Conference Abstract
Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise
Broocks, A.; Ruther, E.; Munzel, U.; Hajak, G.; Wedekind, D. & Bandelow, B. (2000)
European Psychiatry, 15
Paris cedex 15: Editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/S0924-9338(00)94044-6
Details DOI WoS

2000 | Journal Article
The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
Bandelow, B.; Broocks, A.; Pekrun, G.; George, A.; Meyer, T.; Pralle, L. & Bartmann, U. et al. (2000)
Pharmacopsychiatry, 33(5) pp. 174-181. DOI: https://doi.org/10.1055/s-2000-12982
Details DOI PMID PMC WoS

2000 | Journal Article | Letter Note
Myocarditis associated with clozapine treatment
Degner, D.; Bleich, S.; Grohmann, R.; Bandelow, B. & Ruther, E. (2000)
Australian and New Zealand Journal of Psychiatry, 34(5). DOI: https://doi.org/10.1080/j.1440-1614.2000.0822n.x
Details DOI PMID PMC WoS

2000 | Journal Article
Advances in the pharmacotherapy of depression by new antidepressants
Broocks, A.; Junghanns, K.; Thiel, A.; Gleiter, C. H. & Bandelow, B. (2000)
Fortschritte der Neurologie · Psychiatrie, 68(1) pp. 17-24. DOI: https://doi.org/10.1055/s-2000-11639
Details DOI PMID PMC WoS

2000 | Journal Article
Confusion and excitability of initially undetermined cause in the course of poisoning with deadly nightshade in attempted suicide: symptoms, differential diagnosis, toxicology and physostigmine treatment of an anticholinergic syndrome
Heindl, S.; Binder, C.; Desel, H.; Matthies, U.; Lojewski, I.; Bandelow, B. & Kahl, G. F. et al. (2000)
DMW - Deutsche Medizinische Wochenschrift, 125(45) pp. 1361-1365. DOI: https://doi.org/10.1055/s-2000-8178
Details DOI PMID PMC WoS

2000 | Journal Article
Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder
Pauls, J.; Bandelow, B.; Ruther, E. & Kornhuber, J. (2000)
Journal of Neural Transmission, 107(11) pp. 1361-1366. DOI: https://doi.org/10.1007/s007020070023
Details DOI PMID PMC WoS

2000 | Journal Article
Salivary, total plasma and plasma free cortisol in panic disorder
Wedekind, D.; Bandelow, B.; Broocks, A.; Hajak, G. & Ruther, E. (2000)
Journal of Neural Transmission, 107(7) pp. 831-837. DOI: https://doi.org/10.1007/s007020070062
Details DOI PMID PMC WoS

2000 | Journal Article
Plasma homocysteine is a predictor of alcohol withdrawal seizures
Bleich, S.; Degner, D.; Bandelow, B.; von Ahsen, N.; Ruther, E. & Kornhuber, J. (2000)
Neuroreport, 11(12) pp. 2749-2752. DOI: https://doi.org/10.1097/00001756-200008210-00028
Details DOI PMID PMC WoS

2000 | Journal Article
Diurnal variation of cortisol in panic disorder
Bandelow, B.; Wedekind, D.; Sandvoss, V.; Broocks, A.; Hajak, G.; Pauls, J. & Peter, H. et al. (2000)
Psychiatry Research, 95(3) pp. 245-250. DOI: https://doi.org/10.1016/S0165-1781(00)00183-9
Details DOI PMID PMC WoS

2000 | Journal Article
Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder
Broocks, A.; Bandelow, B.; George, A.; Jestrabeck, C.; Opitz, M.; Bartmann, U. & Gleiter, C. H. et al. (2000)
International Clinical Psychopharmacology, 15(3) pp. 153-161. DOI: https://doi.org/10.1097/00004850-200015030-00004
Details DOI PMID PMC WoS

2001 | Journal Article
Generalized anxiety disorders - A neglected illness? Background and aims of the GAD-P-Study
Wittchen, H.-U.; Linden, M.; Schwarzer, W.; Riemann, D.; Boerner, R. J. & Bandelow, B. (2001)
MMW-FORTSCHRITTE DER MEDIZIN, pp. 1-4.
Details WoS

2001 | Conference Abstract
Increased psychobehavioral responsiveness to M-chlorophenylpiperazine (m-CPP) and ipsapirone (IPS) in patients with panic disorder (PDA)
Broocks, A.; Bandelow, B.; George, A. & Roed, I. S. (2001)
Journal of Neurochemistry, 78
Oxford: Blackwell Science Ltd.
Details WoS

2001 | Journal Article
Separation anxiety and actual separation experiences during childhood in patients with panic disorder
Bandelow, B.; Tichauer, G. A.; Spath, C.; Broocks, A.; Hajak, G.; Bleich, S. & Ruther, E. (2001)
The Canadian Journal of Psychiatry, 46(10) pp. 948-952.
Details PMID PMC WoS

2001 | Journal Article
Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology
Doering, S.; Wedekind, D.; Pilz, J.; Bandelow, B.; Adler, L. & Huether, G. (2001)
ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 47(1) pp. 42-57.
Details PMID PMC WoS

2001 | Journal Article
Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects
Broocks, A.; Meyer, T.; Gleiter, C. H.; Hillmer-Vogel, U.; George, A.; Bartmann, U. & Bandelow, B. (2001)
Psychopharmacology, 155(3) pp. 234-241. DOI: https://doi.org/10.1007/s002130100706
Details DOI PMID PMC WoS

2002 | Conference Abstract
How long to treat anxiety disorders?
Bandelow, B. (2002)
European Neuropsychopharmacology, 12 pp. S159-S160.
Amsterdam: Elsevier Science Bv.
Details WoS

2002 | Conference Abstract
Sertraline versus paroxetine in the treatment of panic disorder: A multinational randomized double-blind 15 week study
Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Dombrowski, A. & Goebel, C. (2002)
European Neuropsychopharmacology, 12
Amsterdam: Elsevier Science Bv.
Details WoS

2002 | Conference Abstract
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
Broocks, A.; Hajak, G.; Bandelow, B.; Koch, K.; Schweiger, U. & Hohagen, F. (2002)
European Psychiatry, 17
Paris cedex 15: Editions Scientifiques Medicales Elsevier.
Details WoS

2002 | Journal Article
Quick sedation of the agitated patient with zyprexa velotab - Innovation in acute psychiatric care
Bandelow, B. (2002)
NERVENHEILKUNDE, 21(5) pp. 75-76.
Details WoS

2002 | Journal Article
Evaluating the efficacy of psychological therapy
Bandelow, B. & Broocks, A. (2002)
Verhaltenstherapie, 12(3) pp. 205-215. DOI: https://doi.org/10.1159/000066571
Details DOI WoS

2002 | Journal Article
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
Bandelow, B.; Spath, C.; Tichauer, G. A.; Broocks, A.; Hajak, G. & Ruther, E. (2002)
Comprehensive Psychiatry, 43(4) pp. 269-278. DOI: https://doi.org/10.1053/comp.2002.33492
Details DOI PMID PMC WoS

2002 | Journal Article
Assessing the severity of panic disorder and agoraphobia: Validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A)
Tural, U.; Fidaner, H.; Alkin, T. & Bandelow, B. (2002)
Journal of Anxiety Disorders, 16(3) art. PII S0887-6185(02)00104-4. DOI: https://doi.org/10.1016/S0887-6185(02)00104-4
Details DOI PMID PMC WoS

2002 | Journal Article
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
Broocks, A.; Bandelow, B.; Koch, K.; Bartmann, U.; Kinkelbur, J.; Schweiger, U. & Hohagen, F. et al. (2002)
Neuropsychopharmacology, 27(2) art. PII S0893-133X(02)00298-1. DOI: https://doi.org/10.1016/S0893-133X(02)00298-1
Details DOI PMID PMC WoS

2003 | Conference Abstract
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Degner, D.; Bandelow, B.; Akkan, R.; Kropp, S.; Nietmann, P. D.; Ruther, E. & Bleich, S. (2003)
Pharmacopsychiatry, 36(5) 23rd Symposium of the Arbeitsgemeinschaft-Neuropsychopharmakologie-und-Pharmakopsychiatrie (AGNP), MUNICH, GERMANY.
Stuttgart: Georg Thieme Verlag Kg.
Details WoS

2003 | Journal Article
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo
Broocks, A.; Meyer, T.; Opitz, M.; Bartmann, U.; Hillmer-Vogel, U.; George, A. & Pekrun, G. et al. (2003)
European Neuropsychopharmacology, 13(3) pp. 153-164. DOI: https://doi.org/10.1016/S0924-977X(02)00177-3
Details DOI PMID PMC WoS

2003 | Journal Article
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism
Bleich, S.; Bandelow, B.; Javaheripour, K.; Mueller, A.; Degner, D.; Wilhelm, J. & Havemann-Reinecke, U. et al. (2003)
Neuroscience Letters, 335(3) art. PII S0304-3940(02)01194-1. DOI: https://doi.org/10.1016/S0304-3940(02)01194-1
Details DOI PMID PMC WoS

2004 | Review
Treatment-resistant panic disorder
Bandelow, B.& Ruther, E. (2004)
CNS Spectrums, 9(10) pp. 725-+.
M B L Communications, Inc.
Details PMID PMC WoS

2004 | Conference Abstract
Escitalopram in the treatment of anxiety symptoms associated with depression
Bandelow, B. & Andersen, H. (2004)
Neuropsychopharmacology, 29 Annual Meeting of the American-College-of-Neuropsychopharmacology, San Juan, PR.
London: Nature Publishing Group.
Details WoS

2004 | Journal Article
Sertraline versus paroxetine in the treatment of panic disorder: An acute, double-blind noninferiority comparison
Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Goebel, C. & Clary, C. M. (2004)
The Journal of Clinical Psychiatry, 65(3) pp. 405-413.
Details PMID PMC WoS

2004 | Journal Article
Acute agranulocytosis after long-term clozapine treatment
Degner, D.; Knievel, A.; Mueller, P.; Bandelow, B.; Schaefer, E.; Grohmann, R. & Ruther, E. (2004)
PSYCHOPHARMAKOTHERAPIE, 11(3) pp. 98-100.
Details WoS

2004 | Journal Article | Letter Note
Sertraline and exposure therapy in social phobia
Bandelow, B. (2004)
The British Journal of Psychiatry, 184. DOI: https://doi.org/10.1192/bjp.184.3.271
Details DOI PMID PMC WoS

2004 | Journal Article
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
Bandelow, B.; Torrente, A. C.; Wedekind, D.; Broocks, A.; Hajak, G. & Ruther, E. (2004)
European Archives of Psychiatry and Clinical Neuroscience, 254(6) pp. 397-405. DOI: https://doi.org/10.1007/s00406-004-0521-2
Details DOI PMID PMC WoS

2005 | Conference Abstract
Investigation of RGS2 and RGS13 gene polymorphisms in human panic disorder
Hohoff, C.; Jung, A.; Freitag, C. M.; Willis-Owen, S. A.; Ponath, G.; Krakowitzky, P. & Fritze, J. et al. (2005)
American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 138B(1) 13th World Congress on Psychiatric Genetics, Boston, MA.
Hoboken: Wiley-liss.
Details WoS

2005 | Journal Article
Oculogyric crisis under aripiprazol in combination with fluoxetin
Degner, D.; Fiege, O.; Bandelow, B.; Grohmann, R. & Ruther, E. (2005)
PSYCHOPHARMAKOTHERAPIE, 12(1) pp. 32-33.
Details WoS

2005 | Conference Abstract
Treatment of anxiety disorders
Bandelow, B. (2005)
European Neuropsychopharmacology, 15 8th Regional Meeting of the European Congress of Neuropathology, Moscow, RUSSIA.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(05)80218-4
Details DOI WoS

2005 | Conference Abstract
Treating anxiety disorders: Efficacy and safety considerations
Bandelow, B. (2005)
European Psychiatry, 20 pp. S153-S154.
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Conference Abstract
Escitalopram in the treatment of anxiety symptoms associated with depression
Bandelow, B. (2005)
European Psychiatry, 20
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Conference Abstract
Treatment of panic anxiety disorder: An update
Bandelow, B. (2005)
European Psychiatry, 20
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Journal Article
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
Naber, D.; Riedel, M.; Klimke, A.; Vorbach, E. U.; Lambert, M.; Kuhn, K. U. & Bender, S. et al. (2005)
Acta Psychiatrica Scandinavica, 111(2) pp. 106-115. DOI: https://doi.org/10.1111/j.1600-0447.2004.00486.x
Details DOI PMID PMC WoS

2005 | Journal Article
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
Bandelow, B.; Krause, J.; Wedekind, D.; Broocks, A.; Hajak, G. & Ruther, E. (2005)
Psychiatry Research, 134(2) pp. 169-179. DOI: https://doi.org/10.1016/j.psychres.2003.07.008
Details DOI PMID PMC WoS

2005 | Review
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Baldwin, D. S.; Anderson, I. M.; Nutt, D. J.; Bandelow, B.; Bond, A.; Davidson, J.& den Boer, J. A. et al. (2005)
Journal of Psychopharmacology, 19(6) pp. 567-596.
Sage Publications Ltd. DOI: https://doi.org/10.1177/0269881105059253
Details DOI PMID PMC WoS

2005 | Journal Article
Pharmacotherapy in personality disorders
Wedekind, D.; Bandelow, B. & Ruther, E. (2005)
Fortschritte der Neurologie · Psychiatrie, 73(5) pp. 259-267. DOI: https://doi.org/10.1055/s-2004-830107
Details DOI PMID PMC WoS

2005 | Journal Article
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges
Kronenberg, G.; Berger, P.; Tauber, R. F.; Bandelow, B.; Henkel, V. & Heuser, I. (2005)
Pharmacopsychiatry, 38(1) pp. 24-29. DOI: https://doi.org/10.1055/s-2005-837768
Details DOI PMID PMC WoS

2005 | Journal Article
The alpha(2)delta subunit off the tension-dependent calcium channel
Wedekind, D. & Bandelow, B. (2005)
Der Nervenarzt, 76(7) pp. 888-891. DOI: https://doi.org/10.1007/s00115-005-1940-7
Details DOI PMID PMC WoS

2006 | Journal Article
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B. (2006)
The Journal of Clinical Psychiatry, 67(11) pp. 1741-1746.
Details PMID PMC WoS

2006 | Conference Abstract
Which factors predict placebo response in anxiety disorders and major depression?
Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B. (2006)
European Neuropsychopharmacology, 16 19th Congress of the European-College-of-Neuropsychopharmacology, Paris, FRANCE.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70618-6
Details DOI WoS

2006 | Conference Abstract
Generalized anxiety disorder (GAD): the treatment implications of clinical heterogeneity
Bandelow, B. (2006)
European Neuropsychopharmacology, 16 19th Congress of the European-College-of-Neuropsychopharmacology, Paris, FRANCE.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70835-5
Details DOI WoS

2006 | Journal Article
Defining response and remission in anxiety disorders: Toward an integrated approach
Bandelow, B. (2006)
CNS Spectrums, 11(10) pp. 21-28.
Details PMID PMC WoS

2006 | Journal Article
Anxiety disorders: Long-term treatment and relapse prevention
Bandelow, B.; Wolff-Menzler, C.; Wedekind, D. & Ruther, E. (2006)
MMW-FORTSCHRITTE DER MEDIZIN, 148(4) pp. 31-34.
Details PMID PMC WoS

2006 | Journal Article
Rgs 2 gene polymorphisms as modulators of anxiety in humans?
Leygraf, A.; Hohoff, C.; Freitag, C. M.; Willis-Owen, S. A.; Krakowitzky, P.; Fritze, J. & Franke, P. E. et al. (2006)
Journal of Neural Transmission, 113(12) pp. 1921-1925. DOI: https://doi.org/10.1007/s00702-006-0484-8
Details DOI PMID PMC WoS

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100